Literature DB >> 10678875

Accuracy of perceptions of hepatitis B and C status. Injecting drug users need vaccination against hepatitis B.

M E Ramsay, M A Balogun, C G Teo, P P Mortimer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10678875      PMCID: PMC1127541     

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  8 in total

1.  Acute hepatitis B in injecting drug users is increasing as initiative to improve vaccine coverage begins.

Authors: 
Journal:  Commun Dis Rep CDR Wkly       Date:  1999-05-21

2.  Accuracy of perceptions of hepatitis B and C status: cross sectional investigation of opiate addicts in treatment.

Authors:  D Best; A Noble; E Finch; M Gossop; C Sidwell; J Strang
Journal:  BMJ       Date:  1999-07-31

3.  Harm minimisation for drug misusers.

Authors:  J Strang; M Farrell
Journal:  BMJ       Date:  1992-05-02

4.  Has the United Kingdom averted an epidemic of HIV-1 infection among drug injectors?

Authors:  G V Stimson
Journal:  Addiction       Date:  1996-08       Impact factor: 6.526

5.  Hepatitis B and admission to medical school.

Authors:  R J Gilson
Journal:  BMJ       Date:  1996-10-05

6.  Mistake in report: hepatitis B vaccination for drug misusers is recommended.

Authors:  J Polkinghorne; J Strang; M Farrell
Journal:  BMJ       Date:  1997-07-05

7.  Evaluation of the new automated enzymun-test anti-HBc plus for the detection of hepatitis B virus core antibody.

Authors:  B Weber; U Michl; A Mühlbacher; G Paggi; V Bossi
Journal:  Intervirology       Date:  1998       Impact factor: 1.763

Review 8.  Risks of chronicity following acute hepatitis B virus infection: a review.

Authors:  K C Hyams
Journal:  Clin Infect Dis       Date:  1995-04       Impact factor: 9.079

  8 in total
  1 in total

1.  Expression and immunoreactivity of an epitope of HCV in a foreign epitope presenting system.

Authors:  Mei Peng; Chang-Bai Dai; Yuan-Ding Chen
Journal:  World J Gastroenterol       Date:  2005-06-14       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.